1. Resting energy expenditure has previously been shown to be elevated in the acute phase of heart failure, but the situation in the compensated state of chronic cardiac failure is unclear. Resting energy expenditure was assessed in 14 patients with stable chronic cardiac failure and 14 matched control subjects by using indirect calorimetry.
INTRODUCTION
An elevated basal metabolism has been demonstrated in the decompensated state of acute heart failure by several groups during the f i s t half of this century [l, 21, and a link between this and the development of cardiac cachexia has been postulated [3] . While many patients may now be maintained symptom-free at rest with the use of potent loop diuretics and other drugs, cardiac cachexia is still only too common [4] . It would seem reasonable to propose that the basal metabolism remains elevated into the chronic phase of heart failure. Certainly, neurohumoral abnormalities and, in particular, elevated levels of noradrenaline are well documented [ 5 ] and it is possible that chronic cardiac failure (CCF) may parallel the high basal metabolism and cachectic state observed in some patients with phaeochromocytoma [6] . Elevated resting noradrenaline levels have been linked with decreased survival in heart failure [7] , and, at least where surgery is involved, cardiac cachexia carries a poor prognosis [8] . The objects of this study were to determine if elevated resting energy expenditure (REE) occurs in the compensated diuretic-treated state of CCF and, if so, what factors might be involved in its aetiology. To measure REE we have employed the technique of indirect calorimetry, which relies on the analysis of respiratory gas exchange, i.e. 0, consumption and CO, production.
METHODS

Patients
Thirteen men and one woman (mean age 62.4 years, range 46-74 years) with compensated CCF took part in the study. Seven patients were in New York Heart Association class II and seven were in class III. The aetiology was ischaemic heart disease in 12, hypertension in one and congenital heart disease in one (ventricular septal defect). The median time from diagnosis was 8 months (range 4-22 months) and all patients had been clinically stable for a minimum of 3 months before the study. The mean left ventricular ejection fraction, as determined by radionuclide angiography, was 0.27 (range 0.09-0.43; normal > OSO), and the cardiothoracic ratio was greater than 0.50 in all cases. Four patients were in atrial fibrillation and 10 were in sinus rhythm. Drug treatment was with diuretics in all patients (median dose of frusemide, 80 mg, range 40-240 mg) and six were taking digoxin. In addition, one patient was taking enalapril, and four were taking flosequinan, a new combined arterioand veno-dilator (Boots Company PLC, Nottingham, U.K.). None had significant pulmonary disease from history or spirometry (defined as forced expiratory volume in 1 s <75% of predicted, or forced expiratory volume in 1 s < 75% of forced vital capacity) and all were stopped by dyspnoea or fatigue on incremental treadmill testing. Clinical evidence of fluid overload (peripheral oedema, elevated venous pressure, basal rales) was absent at the time of the study. No patients were severely wasted clinically.
Control subjects
Thirteen men and one woman (mean age 60.3 years, range 48-67 years), with no cardiac or pulmonary disease, acted as control subjects. They were determined to be healthy on the basis of normal history, examination and exercise test. All were sedentary and were taking no medication.
Ethics
Ethical approval for the study was granted by the Ethical Committee of The Queen's University of Belfast. Informed consent was given by all patients and subjects.
Protocol
Before the study all patients and subjects were familiarized with the apparatus both at rest and during exercise, and on a later separate occasion an incremental treadmill test was performed for determination of peak oxygen consumption (PVo2). On the day of the resting study, subjects attended the laboratory after an overnight fast. Patients omitted their morning medication and no tobacco was permitted over the period of the fast. A urine collection for determination of urea excretion was commenced and, after the insertion of a teflon cannula in an antecubital vein, the subject rested supine for 90 min. After this, blood was withdrawn for estimation of plasma concentrations of noradrenaline and adrenaline, and for serum concentrations of free fatty acids (FFA) and glycerol. Respired gas measurements were taken during 15 min of seated rest. The urine collection was completed at the end of this period.
Measurement of gas exchange and REE Minute ventilation was measured by using a vane turbine placed on the inspiratory side of a non-rebreathing respiratory valve circuit (Hans-Rudolph, Kansas City, KS, U.S.A.; dead-space 88 ml) in conjunction with a ventilometer (PK Morgan, Chatham, Kent, U.K.). Lnterruptions of a light beam by the vane were counted to measure inspired volume, which was then converted to expired ventilation (k) by using the Haldane correction and standard formulae [9] . Expired air was led away from the subject via a large-bore flexible tube (6 cm internal diameter) to a mixing chamber. The combined volume of the tube and mixing chamber was 4.5 litres. Expired air was sampled continuously from the chamber from a point well away from the outlet, at a rate of 1 litre/min, and expired 0, and CO, concentrations were determined by paramagnetic and infrared analysis, respectively (PK Morgan). The outputs from the ventilometer and gas analysers were fed via an analogue-to-digital converter to an Ericsson microcomputer for on-line calculation of minute 0, consumption ( Vo2), minute CO, production ( Vcoq) and k. Data points were averages of 15 s periods.
Calibration of the ventilometer was carried out weekly using multiple strokes of a standard 1 litre syringe, and the gas analysers were calibrated before each test with gases of known concentration. Validation studies showed that the ventilometer accuracy was k 3% at flow rates up to 100 litres/min, the CO, analyser accuracy was L-3% of the test gas value in the range 1.9-5.1% CO,, and the 0, analyser accuracy was L-0.24% of the test gas value in the range 15.8-19.2% 0,. Both analysers were shown to be very stable for a period of at least 30 min (drift of < 0.4% of baseline value in the CO, analyser and no detectable drift in the 0, analyser).
REE calculations were made, by using the modified Weir equation [lo], from Vo2 (ml/min), Vco, (ml/min) and urinary urea-N (g/day) as shown below: REE (kJ/day) = 4.1 86[ 1. 44( 3.9 Vo, + 1.1 Pco,) - 
urinary urea-N]
Calculations were performed by the microcomputer as above using a nutrition software package (Wyvern Software, Andover, NH, U.S.A.).
The principle of indirect calorimetry has recently been validated by comparison with direct calorimetry measurements [ 111. Predicted REE was calculated from the regression equations of Harris & Benedict [ 121. Substrate utilization was determined by using the equations of Lusk [13] . Estimation of REE was made for the period after stability of the respiratory pattern had occurred. This was taken as being the achievement of five pop data points with a coefficient of variation of <5% and this resulted in at least 11 min of respiratory data in all subjects. Heart rate was measured from an ECG signal (DelMar Avionics, Los Angeles, CA, U.S.A.) and was averaged as for the period of stable respiration.
Reproducibility
In order to assess the reproducibility of the gas exchange variables, four patients and 12 control subjects underwent a second estimation of REE on a separate day. The same protocol was followed, with the exception of the urine collection, which was omitted. The value of urinary urea excretion obtained during the first study was used in the calculation of FEE.
Blood sampling and assay
The venous cannula was flushed with 0.9% (w/v) NaCl (saline), avoiding the use of heparin. Samples for determination of catecholamines were mixed with sodium metabisulphite as preservative and chilled. The plasma was separated and stored at -20°C for a maximum of 4 weeks before analysis. Samples for determination of FFA and glycerol were allowed to clot at room temperature and the serum was separated and stored at -20°C. Noradrenaline and adrenaline were measured by h.p.1.c. with electrochemical detection by a modification of the method of Anton & Sayre [14] . FFA were assayed by an enzymic colorimetric method (Wako Laboratories, Neuss, Germany). Glycerol was assayed by an enzymic colorimetric method (Boehringer, Mannheim, Germany). The coefficients of variation for the assays were: FFA, 4.1 5%; glycerol, 4.6%; noradrenaline, 5.0%; adrenaline, 7.3%. The limit of detection for both noradrenaline and adrenaline was approximately 0.18 nmol/l.
Anthropometry
A series of four skinfolds was measured in each subject on the right side of the body: (1) triceps skinfold (measured at the mid-point of the flexed arm), (2) biceps skinfold [measured as (l)], (3) subscapular skinfold (measured obliquely) and (4) supra-iliac skinfold (measured just above the iliac crest in the mid-axillary line). For each skinfold, three measurements were made and the mean value was noted. Measurements were made to the nearest 0.5 mm and the same calipers were used in all subjects (Holtain, Crymych, Dyfed, U.K.). The midarm circumference of the right arm was measured to the nearest millimetre by using a cloth tape. Body fat percentage, and hence fat-free mass, were calculated from the equations of Durnin & Womersley [15] . The revised equations of Heymsfield et al. [16] were used to calculate bone-free arm muscle area. All measurements were made by the same observer (M.R.). For determination of intraobserver reproducibility, readings were taken on 2 consecutive days in 10 patients; the coefficients of variation were 0.7% for estimation of fat-free mass and 4.8% for arm muscle area.
Statistical analysis
By inspection of the data and application of the Kolmogorov-Smirnov one-sample test, results were found not to differ sigdicantly from normality, with the exception of the plasma adrenaline concentration values. Differences between groups were therefore assessed by using the unpaired Student's t-test, apart from the plasma adrenaline concentration data, for which the Mann-Whitney U-test was employed. A probability value of less than 0.05 was taken as the level of statistical significance. The degree to which differences between the groups could be explained by confounding variables was determined, where appropriate, by performing an analysis of covariance. Reproducibility was measured by calculating a coefficient of variation by the method of Bland [ 171.
RESULTS
Pvo, was lower in patients with CCF (17.8 f 4.7 ml min-' kg-', m e a n f s~) than in control subjects (30.9f5.8 ml min-' kg-', P<O.OOOl). Thyriod function was normal in all subjects and there was no significant difference between the two groups. The mean total thyroxine level was 89.9 nmol/l (range 50-136 nmol/l) in patients with CCF and 89.3 nmol/l (range 72-104 nmo1/1) in control subjects. Total body weight and anthropometric data are illustrated in Table 1 . There was a trend towards lower body weight, and fat-free mass was si&cantly lower, in the patients with CCF, but body mass index and percentage body fat were not different between the two groups. A sigmficant reduction in arm muscle area was observed in the patients with CCF.
Resting heart rate was higher in the patients with CCF than in the control subjects, and resting h and vo, showed a similar pattern. The supine plasma concentration of noradrenaline and the supine serum concentrations of FFA and glycerol were all greater in the patients with CCF, but the supine plasma concentration of adrenaline was not significantly different. These data are documented in Table 2 . When the more severely affected patients were compared with those with milder heart min-' kg-I), no significant differences in any of the above measurements were observed.
Reproducibility study
No significant difference in the estimation of REE (Fig.  1) was observed between the first and second study (first study: 7074f 1209 kJ/day; second study: 7116 k 1185 kJ/day; P = 0.84, paired t-test; r=0.93). The coefficient of variation for REE was 4.5%.
REE
REE was significantly elevated in the patients with CCF whether expressed in relation to total body weight or to fat-free mass (Table 3) . When the measured REE was expressed as a percentage of each subject's predicted basal metabolism as calculated from the regression equations of Harris & Benedict, the mean value in the control subjects was close to loo%, but was significantly greater in the patients with CCF. Among the patients with CCF, no differences in REE were found between those with severe and mild disease, catagorized as above.
Analysis of covariance was carried out on the values of FEE, with ventilation, heart rate, plasma noradrenaline concentration and serum FFA concentration as covariates. The results are shown in Tables 4( a ) and 4( b), respectively, for REE expressed in relation to total body weight and in relation to fat-free mass. The crude regression coefficient is the difference in k attributable to a change in group, i.e. k is regressed against group. In both Tables the introduction of h as a covariate resulted in a marked reduction in the crude regression coefficient, indicating that much of the difference in REE between the groups could be accounted for by the difference in h, i.e. the coefficient associated with a change in group is now no longer significant (Fig. 2) . With heart rate, plasma noradrendine concentration and serum FFA concentration, no 5000 7500 10 000 REE in test 1 (kJ/day) Fig. 1 . Reproducibility of measurements of REE in four patients with CCF ( D ) and 12 control subjects ( 0 ) . The REE in the second determination is plotted against that in the first. The line of identity is shown. r=0.925; error SD = 387.6 kJ; coefficient of variation = 4.5%. such fall in the regression coefficient was noted, implying that these covariates cannot explain the differences in REE. Interaction terms were also fitted as covariates, but failed to yield significant values, indicating that changes in k, heart rate and plasma noradrenaline concentration account for similar changes in REE in both groups. A similar analysis of covariance is illustrated in Table 4 (c) for arm muscle area, with REE as the covariate. There was a significant fall in the crude regression coefficient whether REE was expressed in relation to total body weight or fat-free mass, indicating that a significant proportion of the difference in arm muscle area could be accounted for by the difference in REE between the patients with CCF and the control subjects (Fig. 3) .
Resting substrate utilization
patients with CCF and the control subjects (Fig. 3) .
No sigmficant difference in fat utilization between Table 4 . Regression coefficients for REE (a) expressed per kg body weight and (b) corrected for fat-free mass (FFM) before and after adjustment for ventilation, heart rate, plasma noradrenaline concentration and serum FFA concentration as covariates, and (c) the regression coefficients for arm muscle area before and after adjustment by REE as covariate In ( a ) and (b) with no adjustment (top line), the coefficient gives the crude difference between the groups, and is the same as the difference between the means shown in Table  3 . In ( c ) a similar reduction in the crude regression coefficient occurs with REE expressed as per kg total body weight or as per kg FFM. Values are means k SEM. 
DISCUSSION
Our finding of an elevated REE in the diuretic-treated compensated state of CCF extends the results of previous studies in acute heart failure [ l , 2, 18, 191 . Although our patients were asymptomatic at rest, we were, nonetheless, able to demonstrate elevations in heart rate, h, tho,, supine plasma noradrenaline concentration and supine plasma FFA concentration. Tachycardia is well recognized in acute heart failure but the situation in CCF is not always clear [20] . Ib at rest has previously been shown to be slightly elevated but was not associated with an elevated tho, [21] . Additionally, Weber etal. [22] found no difference in vo, at rest among their four patient groups and these discrepancies may possibly relate to the period of observation involved. Our findings of elevated plasma concentrations of noradrenaline but of normal plasma adrenaline concentrations are in keeping with the results of previous studies [5, 231 . FFA levels in heart failure are less well documented but are known to correlate with sympathetic activity in normal subjects [24] and it is perhaps therefore not surprising that we found them to be raised in CCF. The elevated serum glycerol levels would be consistent with increased lipolysis. We used a mouthpiece and noseclip system for measuring gas exchange, and this methodology has been heart failure include increased myocardial vo, [40] and elevated thyroid function [3] . Our data would not suggest an important role for these factors, in view of a lack of confounding influence of heart rate on M E , and of.the normal total thyroxine levels, although the latter do not definitely exclude abnormal thyroid function [41] . Our data appear to show a slight reduction in protein metabolism at rest in CCF. However, there may be an underestimation of urinary urea in patients due to the previously shown to result in higher L% values as compared with a canopy system [25] , perhaps due to the deadspace inherent in the mouthpiece and valve assembly. While we have no reason to believe that this relative increase in h should have been greater in the patients with CCF, we cannot entirely exclude such an effect in influencing the estimation of REE.
The analysis of covariance indicated that most of the elevation in REE in the patients could be accounted for by their increased h, but it is difficult to definitely attribute a causal role to h as the relationship is only associative. Nevertheless, while in normal subjects the work of breathing is only of the order of 2% of REE [26, 27] , it is possible that this is significantly greater when, as in acute heart failure, hyperventilation [28] and reduced pulmonary compliance [29-321 are present. These changes in pulmonary dynamics probably persist into the chronic state [22, 331 and could conceivably increase metabolic rate. Nevertheless, an increase in L% may simply be secondary to an elevated REE, increased h being necessary to sustain the increased gas exchange resulting from the augmented metabolic rate. h is likely to be contributed to further by the increased dead-space to tidal volume ratio found in CCF [21] , resulting in increased wasted h.
A calorigenic effect of catecholamines [34, 351 and FFA [24] could be partially responsible for hypermetabolism, but our data give little support to this hypothesis. We found no difference in plasma adrenalme levels, and the analysis of covariance indicated that the difference in REE could not be accounted for by the elevated plasma noradrenaline levels and serum FFA levels in the patients with CCF. Although it is generally agreed that the sympathetic nervous system is activated in CCF [36, 371, the antecubital venous noradrenaline level is sigdicantly influenced by forearm extraction and production [38] , and may not accurately reflect overall sympathetic activity [39] . As a result, the above analysis needs to be interpreted with caution. urinary urea-N is small.
Implications of increased REE
Coupled with a reduction in food intake [42] resulting from anorexia, nausea and vomiting [43] , an elevated REE could contribute to cardiac cachexia in CCF. Garrow et al. [44] have estimated that REE accounts for 70-75% of total energy expenditure in sedentary individuals, and, as such, is the single most important determinant of weight loss in individuals on a low-calorie diet. While our patients were not frankly cachectic, they did show a reduced fat-free mass, with a sigxuficant reduction in arm muscle area, indicating a diminished muscle mass. Some of the decrease in muscle mass may have been simply due to inactivity and, in addition, as it is likely that cachexia progresses over the space of some time, any relationship between REE and indices of wasting, even if causative, may be complicated. Nevertheless, our data indicate that REE may have an influence on the lower arm muscle area in patients, although again, as the observation is simply an association, it is difficult to draw definite conclusions. Whether FEE, like other resting indices in CCF, such as plasma noradrenaline concentration [7] and left ventricular ejection fraction [45] , may ultimately prove to have prognostic implications is at present unclear.
